Abstract:Background: Renal cell carcinoma (RCC) accounts for more than 90% of cancers in the kidney. RCC is often asymptomatic, as a result people with RCC generally have advanced disease by the time it is discovered and has a poor prognosis compared to other cancers. Therefore, it is necessary to explore its pathogenesis and identify some reliable prognostic biomarker of RCC. miRNAs are emerging as important players in the development and progression of RCC. miR-31-5p has been reported to act as a tumor suppressor in hepatocellular carcinoma (HCC). The aim of this study is to determine the detailed molecular mechanism of miR-31-5p in the progression of RCC and to investigate its potential clinical value. Methods: In this study, RT-qPCR, EdU assay, CCK-8 assay, wound scratch assay, transwell assay, flow cytometry assay and cell cycle assay were performed to detect miR-31-5p expression and its functions in RCC. Moreover, 42 formalin-fixed paraffin-embedded (FFPE) RCC samples were used to analyze the relationship between miR-31-5p expression and patients’ overall survival. Finally, luciferase reporter assay, RT-qPCR assay and western blot were used to explore the association between miR-31-5p and its potential targets. Results: miR-31-5p was significantly down-regulated in RCC tissues and RCC cell lines compared with paired adjacent normal tissues and normal cell lines. miR-31-5p downregulation was associated with poor prognosis in RCC patients. Overexpression of miR-31-5p inhibited RCC cell proliferation, migration and invasion and cell cycle. Conversely, down-regulation of miR-31-5p promoted cell proliferation, migration and invasion. Furthermore, cyclin-dependent kinasec1 (CDK1), a key player in cell cycle regulation, was identified as a functional target of miR-31-5p. Conclusions: Our results suggest that miR-31-5p serves as a tumor suppressor in RCC and is expected to be a molecular biomarker for poor prognosis of RCC. © 2018

Mir-30A-3p Inhibits Renal Cancer Cell Invasion and Metastasis Through Targeting ATG12.

Identification of Mir-30B As an Oncogene in Renal Cell Carcinoma

Mir-30A-5p in the Tumorigenesis of Renal Cell Carcinoma: A Tumor Suppressive Microrna

Identification of Mir-18A-5p As an Oncogene and Prognostic Biomarker in RCC

Retracted: Mir‐30d‐5p Suppresses Proliferation and Autophagy by Targeting ATG5 in Renal Cell Carcinoma

The Putative Tumor Suppressor Microrna-30A-5p Modulates Clear Cell Renal Cell Carcinoma Aggressiveness Through Repression of ZEB2

MicroRNA-30a-3p Functions As a Tumor Suppressor in Renal Cell Carcinoma by Targeting WNT2.

Mir‐143 Inhibits Renal Cell Carcinoma Cells Metastatic Potential by Suppressing ABL2

Mir-30B-5p Up-Regulation Related to the Dismal Prognosis for Patients with Renal Cell Cancer.

Mp88-11 crosstalk between mir-124 and meg3 regulates cell proliferation and metastasis of renal cell carcinoma

Mir-625-3p Promotes Migration and Invasion and Reduces Apoptosis of Clear Cell Renal Cell Carcinoma.

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key Mirnas

Identification of Mir-195-3p As an Oncogene in RCC

Expression of Microrna-30C Via Lentivirus Vector Inhibits the Proliferation and Enhances the Sensitivity of Highly Aggressive Ccrcc Caki-1 Cells to Anticancer Agents.

Identification of Mir-130B As an Oncogene in Renal Cell Carcinoma

MiR-30a Suppresses Clear Cell Renal Cell Carcinoma Proliferation and Metastasis by Targeting LRP6

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma.

MiR-23a-3p Acts As an Oncogene and Potential Prognostic Biomarker by Targeting PNRC2 in RCC.

Mir-101-3p Serves As a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2

Microrna-191-5p Exerts A Tumor Suppressive Role In Renal Cell Carcinoma